Drugs in management of minimal brain dysfunction.
D000661:Amphetamine / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D001307:Auditory Perception / Q000187:drug effects; D002648:Child; D002652:Child Behavior / Q000187:drug effects; D002653:Child Behavior Disorders / Q000188:drug therapy; D002675:Child, Preschool; D003642:Deanol / Q000627:therapeutic use; D004569:Electroencephalography; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008774:Methylphenidate / Q000627:therapeutic use*; D010552:Personality Assessment; D012110:Reserpine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000927:Anticonvulsants; D000928:Antidepressive Agents; D006634:Histamine H1 Antagonists; D014149:Tranquilizing Agents; D008774:Methylphenidate; D003642:Deanol; D012110:Reserpine; D000661:Amphetamine